-
Neuropsychiatric Disease and Treatment
-
Dr Pérez-López (Logout)
My Dovepress
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.
(1494) Article views
Authors: Francis E Lotrich, Bruce G Pollock
Published Date February 2005 , Volume 2005:1(1) Pages 17 - 35 DOI 10.2147/NDT.S
Francis E Lotrich, Bruce G Pollock
University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, Department of Psychiatry, Pittsburgh, PA, USA
Abstract: Selective serotonin reuptake inhibitors (SSRIs) can safely and successfully treat major depression, although a substantial number of patients benefit only partially or not at all from treatment. Genetic polymorphisms may play a major role in determining the response to SSRI treatment. Nonetheless, it is likely that efficacy is determined by multiple genes, with individual genetic polymorphisms having a limited effect size. Initial studies have identified the promoter polymorphism in the gene coding for the serotonin reuptake transporter as moderating efficacy for several SSRIs. The goal of this review is to suggest additional plausible polymorphisms that may be involved in antidepressant efficacy. These include genes affecting intracellular transductional cascades; neuronal growth factors; stress-related hormones, such as corticotropin-releasing hormone and glucocorticoid receptors; ion channels and synaptic efficacy; and adaptations of monoaminergic pathways. Association analyses to examine these candidate genes may facilitate identification of patients for targeted alternative therapies.Determining which genes are involved may also assist in identifying future, novel treatments.
Keywords: pharmacogenetic, pharmacogenomic, depression, SSRI
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio




